Sun Pharma – IPO

rajraisinghani 1,852 views 3 slides Jun 11, 2015
Slide 1
Slide 1 of 3
Slide 1
1
Slide 2
2
Slide 3
3

About This Presentation

No description available for this slideshow.


Slide Content

Sun Pharma – Value of Investing - Raj Raisinghani

Some Facts!! The next Infosys | Creating long-term value—Sun Pharmaceutical It’s only 30 years on that Sun Pharma is hitting its stride, having become one of the world’s most profitable generic drug makers. It’s only 30 years on that the firm is hitting its stride, having become one of the world’s most profitable generic drug makers—net profit for fiscal 2013 stood at Rs.516.55 crore —and India’s biggest pharma company by market value. At Rs.1,21,811 crore , as of 6 December, Sun Pharma’s market value is about three times that of  Dr. Reddy’s Laboratories Ltd , the next most valuable Indian drug maker.

The IPO The company had 2 stock splits in 2010 where 1stock became 5 stocks and in 2012 when 5 stocks became 10. The management of Sun Pharma claims that the amount of Rs 100000 invested in its IPO in 1994 would have cumulatively grown to about Rs 3.3 crores by December 2012 when stock price was Rs 710. With current price of Rs 848.55 it would be close to 4 crore rupees.
Tags